Exchange: NASDAQ·Updated 07:52 PM EDT
VTGN logo

VTGN VistaGen Therapeutics Inc

$0.2361
$0.0101
(4.10%)
Today
Closed $0.2361
$0.001
(0.42%)
After Hours
EarningsNov 12
Mkt Cap$10.93M
Vol404,865.00

About VTGN

Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA.
39

Bearish Sentiment

How do you feel about VTGN?

ozkanman
$VTGN Short positions, once again, scared people and made them sell.... Just patience..... just wait ... 🚀🚀
3
4
defineme44
$VTGN VTGN said it plans to meet with the FDA during the current quarter, which ends tomorrow, 9/30. That means the meeting should occur by then, but the company doesn't necessarily have to announce the FDA feedback by 9/30. The major catalyst is the subsequent update on whether FDA agrees with VTGN's proposed new Phase 3 path for fasedienol. Let's close over .3 🚀🚀🚀
10
Tygalastkings187
$VTGN i would litrally laugh from here it starts running and AH $1 lol that would be epic
1
7
defineme44
$VTGN Itruvone (PH10) is VTGN’s intranasal treatment for major depressive disorder. It has shown positive exploratory Phase 2a results, has FDA Fast Track designation and an open IND, and VTGN has outlined a ~200-patient Phase 2b study. The next major catalyst would be Phase 2b initiation or a partnership/licensing deal. Overlooked but not forgotten Update possible soon 💥 💥 💥
9
tkr
$VTGN are you serious. This has to be a play for all. Look at the pipeline and see what is in the works. I’m tired of trying to wake people up. How can you not buy even a hundred shares. What is that a cartoon of cigarettes . You all don’t want to make money you just want it to come to you without doing a thing. We’ll get this, you want to make money then make money work for you.
9
defineme44
$VTGN The FDA meeting could already be scheduled or completed, but VTGN doesn’t necessarily have to announce the outcome by Sept. 30. The key catalyst will be when Vistagen publicly discloses FDA feedback and the next Phase 3/regulatory plan. 🚀🚀🚀 7 days hold for the 🤑🤑🤑
9
Angela51
$VTGN 7 yrs ago lost 235k on this stock. Been through this a few times. They’ve got or had a lot in the pipeline and always the same outcome. Then the R/S and offerings. Blah Blah Blah. Normal MO for drug companies. So, VTGN came across my path once again now in 2026, and FK Yea I might buy in again, damnit man. Arnold 75 was my name back then. I got banned permanently from stocktwats. Came back as a women, lol
1
6
tkr
$VTGN if this goes over .40 again it’s telling us something. Getting in soon. This could hit $5 by next week
8
tkr
$VTGN something is going on. News was to suppose to drop today. Thats what all the experts and even CEO said. Now we wait. I wanted to get in a few days ago so I bought a few shares but after reading two days ago that maybe great news was about to hit I said let’s get lucky and invest in 5000 shares instead of buying more Data Center stocks. I do feel something is about to happen. A good 3rd stage outcome or some great news. I think by Monday close we will hear something. Good luck to all who are in this and if what I feel is true. Lilly is about to dive in and we will be at $5 real quick .lets go LLY or even J&J I don’t care but let’s do something lol
1
5
Drugdoctor
$VTGN The BIG BOYS brought this down in the early pre markets to load up. When they are finished, they will take it back up again. This stock should be trading over $1.00 now with those successful PHASE 3 results.
7
Drugdoctor
$VTGN Huge NEWS! SAN FRANCISCO, Calif. , Sept. 22, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clinical-stage biopharma company leveraging nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced preliminary positive data from the open-label extension (OLE) portion of its PALISADE-4 Phase 3 study of fasedienol for the acute treatment of social anxiety disorder. In a recent analysis of subjects who elected to participate in the OLE portion of PALISADE-4 (safety population: N=322), administration of 3.2 µg of fasedienol, taken as needed up to six times per day in anxiety-provoking social and performance situations in everyday life for up to 12 months, was well-tolerated with no new drug-related safety findings. Exploratory efficacy data over the first four months of as-needed treatment demonstrated improvement over time on both the Liebowitz Social Anxiety Scale and the Social Phobia Inventory.
7
Drugdoctor
$VTGN The BOTTOM is IN! The anti-anxiety market - (think Prozac and Xanax), is HUGE! Successful PHASE 3 study is HUGE. The stock should now resume the rally since a lot of traders are gone!
7
Tygalastkings187
$VTGN 0.31-0.32-0.33-0.34-0.35-0.36-0.37-0.38-0.39-0.40-0.41-0.42-0.43-0.44-0.45-0.46-0.47-0.48-0.49-0.50 then $1💥🚀🔥💎💎💎💎💎💎💎💎💎💎
1
3
focafoca99
$VTGN presented positive exploratory data for fasedienol in very severe social anxiety disorder at Psych Congress 2026.
6
Haimalon
$VTGN As one that invest with BIo for years here is one rule that you should know : as long there is no news the share price will continue to bleed slowly …”
4
hooda
$VTGN we have two catalysts waiting for us on the horizon. Fasedienol, the nasal spray for social anxiety and Refisolone the nasal spray for hot flashes. Both are non hormonal products. While Fasedienol gave mixed signals in its phase 3 trials across the *general* group of study participants the REAL takeaway was that for a sub group of subjects, those with *severe* anxiety per the Liebowitz Social Anxiety Scale (LSAS) the Fasedienol was STATISTICALLY SIGNIFICANT in alleviating their severe-anxiety response. I’m thinking Vistagen does not have to wait for more research just to get approval for those suffering the most severe levels of social anxiety according to the LSAS. I am looking for news on this item much sooner than later now, and then, not long after a Hot-Flashes-Be-Gone-Just-Like-That! crowd pleasing surprise waiting in the wings
5
Tradingistheway
$VTGN * Today, Sept. 24, Vistagen reported positive exploratory findings for fasedienol in patients with very severe social anxiety disorder.
1
2
Johnnyshots
$VTGN After we break the .38 wall. If not now AH party should be hosted at the VTGN club. Tickets .38 at the door. Maybe higher if there is a line up. Get your dancing shoes ready !
5
joe77w
$VTGN .75 with short term study, Company Is severely undervalued imo, market cap 13 mln USD for potential yet not approved products with Total addressable market worth billions dollars and trading for less than market cap. I Hope FDA meeting did well. We should know at any moment. If Company did not have green light by FDA 15/20 cents likely then I would buy to bet for a Reverse Merger or business combination or asset sale.
4
Haimalon
$VTGN Guys , what do you think will happen if they will receive the green light for another phase 3 and what if not … Any estimations for the share price ?
1
1

Advertisement|Remove ads.